Literature DB >> 16099894

Temperature dependence of speed of actin filaments propelled by slow and fast skeletal myosin isoforms.

R Rossi1, M Maffei, R Bottinelli, M Canepari.   

Abstract

It was shown that the temperature sensitivity of shortening velocity of skeletal muscles is higher at temperatures below physiological (10-25 degrees C) than at temperatures closer to physiological (25-35 degrees C) and is higher in slow than fast muscles. However, because intact muscles invariably express several myosin isoforms, they are not the ideal model to compare the temperature sensitivity of slow and fast myosin isoforms. Moreover, temperature sensitivity of intact muscles and single muscle fibers cannot be unequivocally attributed to a modulation of myosin function itself, as in such specimen myosin works in the structure of the sarcomere together with other myofibrillar proteins. We have used an in vitro motility assay approach in which the impact of temperature on velocity can be studied at a molecular level, as in such assays acto-myosin interaction occurs in the absence of sarcomere structure and of the other myofibrillar proteins. Moreover, the temperature modulation of velocity could be studied in pure myosin isoforms (rat type 1, 2A, and 2B and rabbit type 1 and 2X) that could be extracted from single fibers and in a wide range of temperatures (10-35 degrees C) because isolated myosin is stable up to physiological temperature. The data show that, at the molecular level, the temperature sensitivity is higher at lower (10-25 degrees C) than at higher (25-35 degrees C) temperatures, consistent with experiments on isolated muscles. However, slow myosin isoforms did not show a higher temperature sensitivity than fast isoforms, contrary to what was observed in intact slow and fast muscles.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099894     DOI: 10.1152/japplphysiol.00543.2005

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  8 in total

1.  An integrated in vitro and in situ study of kinetics of myosin II from frog skeletal muscle.

Authors:  R Elangovan; M Capitanio; L Melli; F S Pavone; V Lombardi; G Piazzesi
Journal:  J Physiol       Date:  2011-12-23       Impact factor: 5.182

2.  Temperature change does not affect force between regulated actin filaments and heavy meromyosin in single-molecule experiments.

Authors:  Masataka Kawai; Takanori Kido; Martin Vogel; Rainer H A Fink; Shin'ichi Ishiwata
Journal:  J Physiol       Date:  2006-05-18       Impact factor: 5.182

3.  Actomyosin kinetics of pure fast and slow rat myosin isoforms studied by in vitro motility assay approach.

Authors:  Monica Canepari; Manuela Maffei; Emanuela Longa; Michael Geeves; Roberto Bottinelli
Journal:  Exp Physiol       Date:  2012-03-30       Impact factor: 2.969

4.  Contractile properties of muscle fibers from the deep and superficial digital flexors of horses.

Authors:  M T Butcher; P B Chase; J W Hermanson; A N Clark; N M Brunet; J E A Bertram
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-08-11       Impact factor: 3.619

5.  Micromechanical thermal assays of Ca2+-regulated thin-filament function and modulation by hypertrophic cardiomyopathy mutants of human cardiac troponin.

Authors:  Nicolas M Brunet; Goran Mihajlović; Khaled Aledealat; Fang Wang; Peng Xiong; Stephan von Molnár; P Bryant Chase
Journal:  J Biomed Biotechnol       Date:  2012-02-14

Review 6.  Electroactive macromolecular motors as model materials of ectotherm muscles.

Authors:  Toribio Fernández Otero
Journal:  RSC Adv       Date:  2021-06-17       Impact factor: 4.036

7.  Extraction of accurate cytoskeletal actin velocity distributions from noisy measurements.

Authors:  Cayla M Miller; Elgin Korkmazhan; Alexander R Dunn
Journal:  Nat Commun       Date:  2022-08-13       Impact factor: 17.694

8.  A non-invasive imaging for the in vivo tracking of high-speed vesicle transport in mouse neutrophils.

Authors:  Kenji Kikushima; Sayaka Kita; Hideo Higuchi
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.